Practical advice for determining the role of BCR-ABL mutations in guiding tyrosine kinase inhibitor therapy in patients with chronic myeloid leukemia

Elias Jabbour, Susan Branford, Giuseppe Saglio, Dan Jones, Jorge E. Cortes, Hagop M. Kantarjian

Research output: Contribution to journalReview articlepeer-review

69 Scopus citations

Fingerprint Dive into the research topics of 'Practical advice for determining the role of BCR-ABL mutations in guiding tyrosine kinase inhibitor therapy in patients with chronic myeloid leukemia'. Together they form a unique fingerprint.

Medicine & Life Sciences